Global private equity and venture capital news and research

Posts Tagged ‘Vivo Ventures’

3 January 2014

Venture capital-backed Revance eyes Nasdaq IPO

stock brokerage market share listed Venture capital-backed biopharmaceutical company Revance Therapeutics is looking to raise $86.25m via an IPO on the Nasdaq exchange.

25 October 2012

Vivo, Fidelity lead $21m Aclaris Therapeutics financing

skin5_lrg Vivo Ventures and Fidelity Biosciences have led a $21m financing round for dermatology-focused pharmaceutical company Aclaris Therapeutics.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016